Covered recipient · General Payments record
J MARCUS DOWNS
Allopathic & Osteopathic Physicians Colon & Rectal Surgery
General Payments · PY2018–2024
$4,450.28
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $481.23 | 13 |
| Travel and Lodging | $447.20 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| THD AMERICA, INC. | $770.80 | 9 |
| DAVOL INC. | $45.77 | 1 |
| Ethicon US, LLC | $31.67 | 1 |
| ABBVIE INC. | $23.01 | 1 |
| Medtronic, Inc. | $21.75 | 1 |
| Pacira Pharmaceuticals Incorporated | $19.75 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.01 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103657722 | CMS |
| Davol Inc. | $45.77 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127657495 | CMS |
| Ethicon US, LLC | $31.67 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077646748 | CMS |
| Medtronic, Inc. | $21.75 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119498424 | CMS |
| Pacira Pharmaceuticals Incorporated | $19.75 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151246619 | CMS |
| THD America, Inc. | $268.10 | 01/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089506359 | CMS |
| THD America, Inc. | $179.10 | 01/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1089506361 | CMS |
| THD America, Inc. | $22.27 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147438480 | CMS |
| THD America, Inc. | $32.19 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147438492 | CMS |
| THD America, Inc. | $180.24 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147438496 | CMS |
| THD America, Inc. | $7.75 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147438500 | CMS |
| THD America, Inc. | $55.76 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147438504 | CMS |
| THD America, Inc. | $2.21 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147438508 | CMS |
| THD America, Inc. | $23.18 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147438924 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.68 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105921863 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.